| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |